Does ROZANOLIXIZUMAB-NOLI Cause Hospitalisation? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hospitalisation have been filed in association with ROZANOLIXIZUMAB-NOLI. This represents 5.4% of all adverse event reports for ROZANOLIXIZUMAB-NOLI.
19
Reports of Hospitalisation with ROZANOLIXIZUMAB-NOLI
5.4%
of all ROZANOLIXIZUMAB-NOLI reports
1
Deaths
19
Hospitalizations
How Dangerous Is Hospitalisation From ROZANOLIXIZUMAB-NOLI?
Of the 19 reports, 1 (5.3%) resulted in death, 19 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB-NOLI. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB-NOLI Cause?
Myasthenia gravis (57)
Drug ineffective (51)
Headache (48)
Nausea (29)
Diarrhoea (27)
Fatigue (27)
Dyspnoea (19)
Vomiting (17)
Therapy interrupted (15)
Asthenia (14)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which ROZANOLIXIZUMAB-NOLI Alternatives Have Lower Hospitalisation Risk?
ROZANOLIXIZUMAB-NOLI vs RUBIDIUM RB-82
ROZANOLIXIZUMAB-NOLI vs RUCAPARIB
ROZANOLIXIZUMAB-NOLI vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB-NOLI vs RUFINAMIDE
ROZANOLIXIZUMAB-NOLI vs RUPATADINE